NCT04760405

Brief Summary

The current proposal aims to test the feasibility of immune function analysis for Tai Chi Easy (TCE) intervention in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT) with concurrent exploration of health related quality of life (HRQOL).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable multiple-myeloma

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 18, 2021

Completed
21 days until next milestone

Study Start

First participant enrolled

March 11, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2023

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

2.7 years

First QC Date

January 15, 2021

Last Update Submit

August 14, 2024

Conditions

Keywords

Multiple MyelomaStem cell transplantAutologous stem cell transplantationASCTTai Chi

Outcome Measures

Primary Outcomes (12)

  • Determine natural killer cell phenotype

    Determine natural killer (NK) phenotype through peripheral blood analysis

    Baseline

  • Determine natural killer cell phenotype

    Determine natural killer (NK) phenotype through peripheral blood analysis

    Day 14

  • Determine natural killer cell phenotype

    Determine natural killer (NK) phenotype through peripheral blood analysis

    Day 30

  • Determine natural killer cell phenotype

    Determine natural killer (NK) phenotype through peripheral blood analysis

    Day 100

  • Determine NK cell activity

    Determine NK cell activity through peripheral blood analysis

    At baseline

  • Determine NK cell activity

    Determine NK cell activity through peripheral blood analysis

    Day 14

  • Determine NK cell activity

    Determine NK cell activity through peripheral blood analysis

    Day 30

  • Determine NK cell activity

    Determine NK cell activity through peripheral blood analysis

    Day 100

  • Determine immune function

    Determine immune function through peripheral blood analysis of immune factors

    At baseline

  • Determine immune function

    Determine immune function through peripheral blood analysis of immune factors

    Day 14

  • Determine immune function

    Determine immune function through peripheral blood analysis of immune factors

    Day 30

  • Determine immune function

    Determine immune function through peripheral blood analysis of immune factors

    Day 100

Study Arms (1)

Tai Chi Easy Intervention

EXPERIMENTAL

Tai Chi Easy: TCE is a standardized protocol used in several prior studies. TCE has been manualized and has a formal training program for instructors. The protocol is taught as a series of repeated and simple-to-learn movements. Patients will receive two 30-minute small group training sessions (Via Zoom) within 7 days of their scheduled transplant. After the training has been completed the participant will be provided with written (via manual) and electronic (DVD, MP3 file download) materials to continue with self-direct practice throughout the duration of the study.

Other: Tai Chi Easy

Interventions

Patients will receive two 30-minute small group training sessions (Via Zoom) within 7 days of their scheduled transplant. After the training has been completed the participant will be provided with written (via manual) and electronic (DVD, MP3 file download) materials to continue with self-direct practice throughout the duration of the study.

Tai Chi Easy Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Multiple Myeloma planned to undergo bone marrow transplant
  • years or older
  • English speaking
  • General proficiency to read/write in English
  • Able to attend TCE training session per study protocol
  • ECOG performance status 0-1
  • Able to return to study center for routine post-transplant follow up (approximately Day 30 and Day 100)

You may not qualify if:

  • Currently performs Tai Chi, QiQong, or Yoga at least once weekly or more
  • Syncopal event in prior 60 days
  • Concurrent major depressive disorder or anxiety disorder (DSMIV) as determined by treating provider
  • Chronic dizziness or vestibular disorders
  • History of recurrent falls (\>2 in the prior year)
  • Grade 3 or greater neuropathy
  • Grade 3 or greater spinal fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Arizona

Tucson, Arizona, 85724, United States

Location

Mayo Clinic

Jacksonville, Florida, 32224, United States

Location

MeSH Terms

Conditions

Multiple Myeloma

Condition Hierarchy (Ancestors)

Neoplasms, Plasma CellNeoplasms by Histologic TypeNeoplasmsHemostatic DisordersVascular DiseasesCardiovascular DiseasesParaproteinemiasBlood Protein DisordersHematologic DiseasesHemic and Lymphatic DiseasesHemorrhagic DisordersLymphoproliferative DisordersImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Krisstina Gowin, DO

    University of Arizona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2021

First Posted

February 18, 2021

Study Start

March 11, 2021

Primary Completion

November 28, 2023

Study Completion

November 28, 2023

Last Updated

August 16, 2024

Record last verified: 2024-08

Locations